TGEN CEO Abinand Rangesh Buys Shares Amid Insider Activity
Abinand Rangesh, CEO of TGEN, purchased 174,081 shares on June 26, 2026.
Key Points
- On June 26, 2026, TGEN's CEO Abinand Rangesh purchased 174,081 shares, adding to insider activity.
- Shares of TGEN traded at $5.22 on Wednesday, with various institutional investors adjusting their positions.
- Analysts from Roth Capital and H.C. Wainwright have set buy ratings, highlighting interest in TGEN.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 26, 2026, Abinand Rangesh, the Chief Executive Officer of TGEN, bought 174,081 shares of the company. This insider purchase adds to a series of transactions that day, reflecting active engagement from TGEN's leadership.
Other Institutional Activity in TGEN
Several institutional investors made changes to their TGEN holdings. Vanguard Capital Management LLC opened a new position with 769,964 shares valued at approximately $1.97 million. Meanwhile, Bard Associates Inc reduced its stake by 798 shares, holding 688,309 shares worth about $1.76 million. Clear Harbor Asset Management, LLC increased its holdings by 40,000 shares to a total of 650,000 shares, valued at $1.66 million. Portolan Capital Management, LLC trimmed its position slightly by 2,255 shares, ending with 443,555 shares valued at $1.14 million.
Tecogen Inc. Stock Up 70.6%
Shares of TGEN traded at around $5.22 on Wednesday. With a broad range of institutional interest, the stock remains an active choice among investors. While specific financial metrics such as market cap and P/E ratio were not available, the stock's trading activity suggests ongoing interest.
$TGEN stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at Tecogen Inc.
In addition to Rangesh's purchase, other insiders were active on June 26, 2026. Angelina Galiteva bought 25,000 shares at an average price of $5.17. Roger Deschenes, the Chief Accounting Officer, purchased 29,013 shares, while Stephen Lafaille, VP of Business Development, also acquired 29,013 shares. Robert Panora, COO and President, added 9,671 shares to his holdings. These transactions were not part of any prearranged plans, demonstrating direct insider confidence.
Analysts Set New Price Targets
Roth Capital initiated coverage on TGEN with a buy rating and a price target of $15.0 on August 18, 2025. H.C. Wainwright reiterated its buy rating with a target of $4.5 back on March 17, 2023. These ratings underscore analysts' positive outlook on TGEN.
Bottom Line
The recent insider buying by TGEN's CEO and other executives signals confidence in the company's prospects. Institutional investors are also adjusting their positions, indicating varied interest levels. Analyst ratings from Roth Capital and H.C. Wainwright further highlight the stock's potential. As always, keep in mind that 13F filings and insider transactions are backward-looking and may not reflect the current state of holdings.
Get Tecogen Inc. alerts
New 13F filings, insider trades, and analyst moves on $TGEN, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.